Showing 373 news articles about Pregnancy and vertical transmission

Filters Content type: Editors' picks Topic: Pregnancy and vertical transmission

Information about the use of antiretroviral drugs in pregnancy and other aspects of care for HIV-positive women during pregnancy, so as to prevent vertical transmission and ensure the best outcomes for both mother and infant.

PrEP science

NIH study finds lower concentration of PrEP drug in pregnant teens & young women

Editor's pick
National Institutes of Health
10 March 2020
Pregnancy and vertical transmission

Dolutegravir Recommended for Treatment-Naive Expectant Women

Editor's pick
Contagion Live
21 February 2020
Pregnancy and vertical transmission

No HIV transmission among Swiss infants born to mothers with undetectable viral load and who did not receive neonatal PEP

Editor's pick
i-Base
17 February 2020
PrEP science

Researchers launch study to assess safety of PrEP and dapivirine ring in pregnant women

Editor's pick
EurekAlert
11 February 2020
Child developmental issues

US: Neural Tube Defect Prevalence Similar Between Infants Exposed to HIV and General Population

Editor's pick
Contagion Live
16 January 2020
Pregnancy and vertical transmission

New estimates show 14.8 million children globally are HIV-exposed but uninfected

Editor's pick
The Conversation
13 January 2020
Pregnancy and vertical transmission

South Africa steps up its game to end mother-to-child transmission of HIV

Editor's pick
The Conversation
7 January 2020
Pregnancy and vertical transmission

US: Prescribing practices for pregnant women with HIV not aligned with guidelines

Editor's pick
Healio
19 December 2019
Pregnancy and vertical transmission

Sri Lanka eliminates vertical transmission of HIV and syphilis

Editor's pick
UNAIDS
16 December 2019
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
Opportunistic infections

‘No benefit’ in giving HIV-exposed babies co-trimoxazole, study finds

Editor's pick
Avert
25 November 2019
TB transmission & prevention

HIV, Pregnancy and Tuberculosis Medication: Do They Mix?

Editor's pick
Contagion Live
1 November 2019
Child developmental issues

HIV-Negative Babies Born to Women With HIV May Have Compromised Health

Editor's pick
POZ
2 October 2019
Child developmental issues

Folic acid reduces risk of defects linked to dolutegravir

Editor's pick
Baylor College of Medicine
25 July 2019
Access to healthcare

Kenya: 69,000 newborns at risk due to ARVs shortage

Editor's pick
The Nation
24 June 2019
Side effects

A Promising Anti-HIV Drug Poses A Dilemma

Editor's pick
NPR
23 April 2019
Pregnancy and vertical transmission

Elvitegravir boosted with cobicistat: avoid use in pregnancy due to risk of treatment failure and maternal-to-child transmission of HIV-1

Editor's pick
Medicines and Healthcare products Regulatory Agency
17 April 2019
Treatment guidelines

Avoiding Dolutegravir in Young Women With HIV: Time for a Rethink?

Editor's pick
MedPage Today
5 April 2019
Adherence

'Vast majority' of elevated viral load episodes in pregnant women caused by non-adherence

Editor's pick
Healio
2 April 2019
The search for an HIV prevention vaccine

HIV antibody VRC01LS safe prevention strategy for infants

Editor's pick
Healio
12 March 2019
TB transmission & prevention

Tshepiso study: Preventive TB therapy not associated with poor pregnancy outcomes

Editor's pick
Healio
12 March 2019
Global health targets

CROI 2019: Thailand’s strides spanned HIV treatment, prevention and research

Editor's pick
Science Speaks
6 March 2019
Child developmental issues

South Africa urgently needs an antiretroviral pregnancy registry

Editor's pick
Spotlight
29 January 2019
Bad science & bogus treatments

As A Strategy for HIV Prevention, Disabling the CCR5 Gene in Embryos Implanted in HIV-Negative Mothers Makes Zero Sense

Editor's pick
NEJM Journal Watch
3 December 2018